Analgesics (Pharmacies) - Guyana

  • Guyana
  • Revenue in the Analgesics market is projected to reach US$6.73m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 15.19%, resulting in a market volume of US$11.85m by 2028.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$8.22 are generated in 2024.

Key regions: Europe, United States, Canada, India, South Korea

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Guyana is experiencing steady growth due to increasing customer preferences for over-the-counter pain relief medications.

Customer preferences:
Customers in Guyana are increasingly turning to pharmacies for their analgesic needs. This can be attributed to several factors. Firstly, the convenience of purchasing analgesics from pharmacies is a major driver of customer preferences. Pharmacies are easily accessible and offer a wide range of analgesic products, allowing customers to choose the most suitable option for their needs. Additionally, the professional advice and guidance provided by pharmacists further enhance the customer experience and increase trust in the products being purchased.

Trends in the market:
One of the key trends in the Analgesics (Pharmacies) market in Guyana is the rising demand for natural and herbal pain relief products. Customers are becoming more conscious of the potential side effects of traditional analgesics and are seeking alternative options. As a result, pharmacies are expanding their product offerings to include a variety of natural and herbal analgesics. This trend is driven by a growing awareness of the benefits of natural remedies and a desire for more holistic approaches to pain relief. Another trend in the market is the increasing popularity of online pharmacies. Customers are increasingly turning to online platforms to purchase analgesics due to the convenience and ease of the online shopping experience. Online pharmacies offer a wide range of analgesic products, often at competitive prices, and provide the added convenience of home delivery. This trend is expected to continue as more customers embrace the convenience and accessibility of online shopping.

Local special circumstances:
One of the unique aspects of the Analgesics (Pharmacies) market in Guyana is the high prevalence of chronic pain conditions. This can be attributed to factors such as the aging population, sedentary lifestyles, and the high prevalence of certain diseases. As a result, there is a significant demand for analgesics to manage chronic pain. Pharmacies in Guyana are catering to this demand by offering a wide range of analgesic products specifically targeted at chronic pain relief.

Underlying macroeconomic factors:
The steady growth of the Analgesics (Pharmacies) market in Guyana can also be attributed to favorable macroeconomic factors. The country's stable economic growth and increasing disposable incomes have contributed to higher consumer spending on healthcare products, including analgesics. Additionally, the government's focus on improving access to healthcare services has resulted in increased healthcare expenditure, further driving the demand for analgesics. In conclusion, the Analgesics (Pharmacies) market in Guyana is experiencing steady growth due to increasing customer preferences for over-the-counter pain relief medications. The convenience of purchasing analgesics from pharmacies, the rising demand for natural and herbal products, and the increasing popularity of online pharmacies are key trends driving the market. The high prevalence of chronic pain conditions in Guyana and favorable macroeconomic factors also contribute to the market's growth.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)